SkinBioTherapeutics plc (LON:SBTX – Get Free Report)’s share price traded down 10.3% during trading on Saturday . The stock traded as low as GBX 14.80 and last traded at GBX 14.91. 2,573,176 shares traded hands during trading, an increase of 127% from the average session volume of 1,133,048 shares. The stock had previously closed at GBX 16.63.
SkinBioTherapeutics Trading Down 10.3%
The company has a current ratio of 0.93, a quick ratio of 10.01 and a debt-to-equity ratio of 27.57. The stock has a market cap of £38.58 million, a P/E ratio of -11.93 and a beta of 2.01. The firm’s 50-day simple moving average is GBX 15.60 and its 200 day simple moving average is GBX 16.15.
SkinBioTherapeutics Company Profile
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Featured Articles
- Five stocks we like better than SkinBioTherapeutics
- How to Calculate Inflation Rate
- Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast
- Using the MarketBeat Dividend Yield Calculator
- Five Below and Dollar Tree Earnings Signal a Shopper Shift
- Growth Stocks: What They Are, Examples and How to Invest
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
